lavender tirzepatide Sky semaglutide: complete guide to plans, pricing, and what to expect Lilly Shows Tirzepatide Superiority in

Food and Drug Administration (FDA) authorized the use of Semaglutide in June 2021 for weight management in adults suffering from obesity or who are overweight and have at least one weight-related condition

Tirzepatide is an advanced weight loss injection that combines the power of two hormones, GLP-1 and GIP, to effectively manage appetite and blood sugar levels

There was some evidence of publication bias (Egger test, P = 0.94), but the trim-and-fill method indicated that this publication bias did not impact the estimate

Despite this distinction, both medications offer similar benefits in weight loss, with clinical studies showing significant weight reduction, particularly with Wegovy

And while GLP-1 patients should be consciously consuming more healthy foods, there are also certain foods to avoid on GLP-1s